Glenn S. Boehnlein Reports Initial Beneficial Ownership in DexCom, Inc.
DEXCOM INC
Subscribe to track DXCM
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Initial Form 3 Filing: DexCom, Inc. ($DXCM)
Reporting Insider: Glenn S. Boehnlein (Director) Event Date: September 10, 2026
Holdings Reported: • Security: Common Stock • Shares Held: 42 shares • Ownership: Indirect (via Boehnlein 2017 Trust)
Significance: Low (Standard initial Form 3 disclosure following appointment/designation as Director).
Comprehensive Analysis
DexCom, Inc. (DXCM) - Form 3 Initial Statement of Beneficial Ownership
Overview
On September 10, 2026, Glenn S. Boehnlein filed an initial statement of beneficial ownership of securities (Form 3) with the SEC in his capacity as a Director of DexCom, Inc. (NASDAQ: DXCM).
Beneficial Ownership Details
- Security Class: Common Stock
- Reported Ownership: 42 shares
- Nature of Ownership: Indirect (
I) via the Boehnlein 2017 Trust, for which the reporting person and their spouse serve as co-trustees. - Derivative Securities: None reported.
Summary & Market Significance
This is a standard Form 3 filing required upon becoming a Section 16 insider (Director) of the company. With an initial holding of 42 shares held via a family trust and no new transactions reported, this filing carries Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.